Adeptrix is an entrepreneurial life sciences company based in Beverly MA that develops analytical solutions for pharma, biopharma, academic and clinical customers. Using its proprietary BAMS™ platform, the company aims to become a major player in the fast-growing, multi-billion dollar bioanalytical consumables market. Adeptrix is currently working with several top universities and research institutions on the development of diagnostic assays for neurology, oncology and virology (COVID-19).